The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Barry Richard since 2016.
This trader's CIK number is 1562371.
At the time of last reporting, Barry Richard was the President & CEO of Cassava Sciences Inc. (stock ticker symbol SAVA).
Also see all insider trading activities at Cassava Sciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | SAVA | 245,113 | $540,274 | 0 | $0 | 0 | $0 |
| 2024 | SAVA | 0 | $0 | 0 | $0 | 176,085 | $3,873,870 |
| 2023 | SAVA | 107,318 | $2,600,749 | 0 | $0 | 0 | $0 |
| 2022 | SAVA | 36,159 | $860,222 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | SRPT | 0 | $0 | 0 | $0 | 32,596 | $796,663 |
| 2023 | SRPT | 50,000 | $3,940,500 | 0 | $0 | 0 | $0 |
| 2020 | SRPT | 0 | $0 | 60,000 | $9,010,350 | 0 | $0 |
| 2019 | SRPT | 18,700 | $1,999,799 | 0 | $0 | 0 | $0 |
| 2018 | SRPT | 0 | $0 | 75,000 | $9,775,500 | 0 | $0 |
| 2016 | SRPT | 75,000 | $1,174,200 | 0 | $0 | 0 | $0 |
1. Cassava Sciences Inc (SAVA)
2. Sarepta Therapeutics, Inc. (SRPT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-22 | SAVA | Buy | 7,172 | 2.28 | 16,352 |
| 2025-09-18 | SAVA | Buy | 190,633 | 2.19 | 416,533 |
| 2025-09-19 | SAVA | Buy | 47,308 | 2.27 | 107,389 |
| 2024-04-23 | SAVA | Option Ex | 176,085 | 22.00 | 3,873,870 |
| 2023-08-21 | SAVA | Buy | 1,906 | 16.80 | 32,020 |
| 2023-08-22 | SAVA | Buy | 16,571 | 16.65 | 275,907 |
| 2023-03-06 | SAVA | Buy | 11,565 | 26.13 | 302,193 |
| 2023-03-07 | SAVA | Buy | 77,276 | 25.76 | 1,990,629 |
| 2022-08-23 | SAVA | Buy | 36,159 | 23.79 | 860,222 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-16 | SRPT | Option Ex | 12,350 | 32.63 | 402,980 |
| 2025-05-13 | SRPT | Option Ex | 20,246 | 19.45 | 393,683 |
| 2023-11-03 | SRPT | Buy | 50,000 | 78.81 | 3,940,500 |
| 2020-08-07 | SRPT | Sale | 30,000 | 158.76 | 4,762,800 |
| 2020-05-15 | SRPT | Sale | 30,000 | 141.59 | 4,247,550 |
| 2019-09-12 | SRPT | Buy | 1,691 | 87.49 | 147,950 |
| 2019-09-13 | SRPT | Buy | 3,309 | 87.49 | 289,504 |
| 2019-08-20 | SRPT | Buy | 5,000 | 99.32 | 496,595 |
| 2019-08-14 | SRPT | Buy | 3,700 | 122.50 | 453,250 |
| 2019-08-14 | SRPT | Buy | 3,700 | 122.50 | 453,250 |
| 2019-08-12 | SRPT | Buy | 1,300 | 122.50 | 159,250 |
| 2018-06-27 | SRPT | Sale | 75,000 | 130.34 | 9,775,500 |
| 2016-03-14 | SRPT | Buy | 75,000 | 15.66 | 1,174,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barry Richard (President & CEO of Cassava Sciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.